← Open Payments lookup

ALLISON HAYES: Open Payments

NPI 1154879674 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$490 in 25 payments from 9 companies in 2025. Trend: 2023 $223 · 2024 $39 · 2025 $490

Food & beverage: $490
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$176
Takeda Pharmaceuticals U.S.A., Inc.4$78
Tris Pharma Inc3$61
Supernus Pharmaceuticals, Inc.2$49
Corium, LLC3$45
ABBVIE INC.1$29
Teva Pharmaceuticals USA, Inc.1$22
Bausch Health US, LLC1$16
Axsome Therapeutics, Inc.1$14

Products named: CAPLYTA, TRINTELLIX, Dyanavel XR, Qelbree, Azstarys, VRAYLAR, AUSTEDO XR, APLENZIN.

Industry payments across CT — which companies pay providers there.